Uplizna is a prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive.
Neuromyelitis optica spectrum disorder (NMOSD) is an unpredictable autoimmune disease. The condition is caused by inflammation in the central nervous system, which is made up of the optic nerve, brain stem and spinal cord. Without treatment, continued inflammation can lead to severe attacks that can result in permanent disability.
Uplizna is proven to reduce relapses that may lead to permanent disability.
Uplizna is the only twice-yearly treatment for neuromyelitis optica spectrum disorder (NMOSD). The treatment is administered with 90-minute intravenous (IV) infusions twice a year (after initial two start-up doses).
The most common side effects include urinary tract infection and joint pain. Uplizna may cause serious side effects, including infusion reactions, infections, Hepatitis B virus (HBV) reactivation, Progressive Multifocal Leukoencephalopathy (PML), Tuberculosis (TB), and low blood cell counts. Before starting treatment with Uplizna, your healthcare provider will do blood tests to check for hepatitis B viral infection and tuberculosis.
For a full list of potential side effects, please see the Important Safety Information and Medication Guide on the Uplizna website.
We offer expert infusion therapy without the hassle or cost of the hospital. We employ highly trained medical staff that work with health insurance companies & physicians to provide our patients with convenient care.
At Omega Health Clinics, we’re committed to offering affordable treatment, with upfront pricing and no hidden costs. Here’s how we make it happen.
